Cargando…

Blue Light Blocking Treatment for the Treatment of Bipolar Disorder: Directions for Research and Practice

Recent results from a small number of clinical studies have resulted in the suggestion that the process of blocking the transmission of shorter-wavelength light (‘blue light’ with a wave length of 450 nm to 470 nm) may have a beneficial role in the treatment of bipolar disorder. This critical review...

Descripción completa

Detalles Bibliográficos
Autores principales: Mylona, Ioanna, Floros, Georgios D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911317/
https://www.ncbi.nlm.nih.gov/pubmed/35268469
http://dx.doi.org/10.3390/jcm11051380
_version_ 1784666768244998144
author Mylona, Ioanna
Floros, Georgios D.
author_facet Mylona, Ioanna
Floros, Georgios D.
author_sort Mylona, Ioanna
collection PubMed
description Recent results from a small number of clinical studies have resulted in the suggestion that the process of blocking the transmission of shorter-wavelength light (‘blue light’ with a wave length of 450 nm to 470 nm) may have a beneficial role in the treatment of bipolar disorder. This critical review will appraise the quality of evidence so far as to these claims, assess the neurobiology that could be implicated in the underlying processes while introducing a common set of research criteria for the field.
format Online
Article
Text
id pubmed-8911317
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89113172022-03-11 Blue Light Blocking Treatment for the Treatment of Bipolar Disorder: Directions for Research and Practice Mylona, Ioanna Floros, Georgios D. J Clin Med Review Recent results from a small number of clinical studies have resulted in the suggestion that the process of blocking the transmission of shorter-wavelength light (‘blue light’ with a wave length of 450 nm to 470 nm) may have a beneficial role in the treatment of bipolar disorder. This critical review will appraise the quality of evidence so far as to these claims, assess the neurobiology that could be implicated in the underlying processes while introducing a common set of research criteria for the field. MDPI 2022-03-02 /pmc/articles/PMC8911317/ /pubmed/35268469 http://dx.doi.org/10.3390/jcm11051380 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Mylona, Ioanna
Floros, Georgios D.
Blue Light Blocking Treatment for the Treatment of Bipolar Disorder: Directions for Research and Practice
title Blue Light Blocking Treatment for the Treatment of Bipolar Disorder: Directions for Research and Practice
title_full Blue Light Blocking Treatment for the Treatment of Bipolar Disorder: Directions for Research and Practice
title_fullStr Blue Light Blocking Treatment for the Treatment of Bipolar Disorder: Directions for Research and Practice
title_full_unstemmed Blue Light Blocking Treatment for the Treatment of Bipolar Disorder: Directions for Research and Practice
title_short Blue Light Blocking Treatment for the Treatment of Bipolar Disorder: Directions for Research and Practice
title_sort blue light blocking treatment for the treatment of bipolar disorder: directions for research and practice
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911317/
https://www.ncbi.nlm.nih.gov/pubmed/35268469
http://dx.doi.org/10.3390/jcm11051380
work_keys_str_mv AT mylonaioanna bluelightblockingtreatmentforthetreatmentofbipolardisorderdirectionsforresearchandpractice
AT florosgeorgiosd bluelightblockingtreatmentforthetreatmentofbipolardisorderdirectionsforresearchandpractice